483 Guangzhou Baiyunshan JingxiuTang Pharmaceutical May 2017

483 Guangzhou Baiyunshan JingxiuTang Pharmaceutical May 2017

Steven Kehoe FDA$119.00 - Available Now

FDA investigators audited the Guangzhou Baiyunshan JingxiuTang Pharmaceutical - Guangzhou, China facility and issued inspectional observations (via FDA 483) on 12 May 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 12 May 2017
  • Location: Guangzhou, China
  • FEI: 3006010954
Add To Cart